65--John Cochran Division 915 N. Grand Blvd St Louis, MO 63106-1621 Turbohawk(atherectomy catheter) purchased from Covidien /EV3

The Cardiovascular Lab at the John Cochran Division located in St. Louis, Missouri, which has a compelling need for EV3/Covidien s' products. These products are used for patient procedures performed by the Interventional Cardiologist and Vascular Surgeons at the St Louis VA. This acquisition will be issued as a justification and approval (J &A) for other than Full and Open Competition for (Spider FX) embolic protection device and (Turbohawk) atherectomy catheter. The directional atherectomy catheter is a FDA approved plaque excision catheter that uses a tiny directional blade to shave away and remove plaque from inside the artery. The directional atherectomy catheter provides the physician with a frontline plaque excision solution in treating multiple vessel lesions which contributes to: maximum luminal gain, minimizes barotrauma, preserves the native vessel for future treatment options, prevents limb loss, and relieves symptoms. This acquisition is for a onetime buy and anticipated solicitation issuance date is on or about August 21, 2014. All responsible sources may submit a quote which shall be considered by this agency. A fax or e-mail response will only be accepted. The fax number is +1 (555) 000-0000. Email address is contact@example.gov. The Contracting Office is: Network Contracting Office (NCO 15), and 3450 S. 4th Street Traffic Way, Leavenworth, KS 66048-5055. Point of Contact is Shiela Morrall, Contracting Officer, +1 (555) 000-0000.